SEC 13F Intelligence

Lsv Asset Management / JAZZ

Lsv Asset Management’s Jazz Pharmaceuticals PLC Position

Does Lsv Asset Management own Jazz Pharmaceuticals PLC (JAZZ)? Yes — 2.39M shares worth $451M (+0.97% of its 13F portfolio) as of Q1 2026, down from 2.46M shares the prior filed quarter.

Position Value
$451M
Q1 2026
Shares
2.39M
% of Portfolio
+0.97%
Quarters Held
30
currently held

Position History JAZZ

Reported value by quarter
Q4 ’18: $95MQ4 ’18Q1 ’19: $143MQ2 ’19: $161MQ3 ’19: $221MQ4 ’19: $279MQ4 ’19Q1 ’20: $186MQ2 ’20: $246MQ3 ’20: $348MQ4 ’20: $375MQ4 ’20Q1 ’21: $341MQ2 ’21: $351MQ3 ’21: $245MQ4 ’21: $234MQ4 ’21Q1 ’22: $281MQ2 ’22: $270MQ3 ’22: $235MQ4 ’22: $328MQ4 ’22Q1 ’23: $339MQ2 ’23: $287MQ3 ’23: $307MQ4 ’23: $288MQ4 ’23Q1 ’24: $287MQ2 ’24: $265MQ3 ’24: $278MQ4 ’24: $312MQ4 ’24Q1 ’25: $306MQ2 ’25: $271MQ3 ’25: $331MQ4 ’25: $418MQ4 ’25Q1 ’26: $451Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.39M$451M+0.97%
Q4 20252.46M$418M+0.91%
Q3 20252.51M$331M+0.73%
Q2 20252.55M$271M+0.63%
Q1 20252.47M$306M+0.73%
Q4 20242.53M$312M+0.72%
Q3 20242.49M$278M+0.60%
Q2 20242.48M$265M+0.58%
Q1 20242.38M$287M+0.59%
Q4 20232.34M$288M+0.63%
Q3 20232.37M$307M+0.71%
Q2 20232.32M$287M+0.63%
Q1 20232.32M$339M+0.76%
Q4 20222.06M$328M+0.72%
Q3 20221.76M$235M+0.55%
Q2 20221.73M$270M+0.58%
Q1 20221.81M$281M+0.52%
Q4 20211.84M$234M+0.41%
Q3 20211.88M$245M+0.44%
Q2 20211.98M$351M+0.60%
Q1 20212.07M$341M+0.58%
Q4 20202.27M$375M+0.68%
Q3 20202.44M$348M+0.71%
Q2 20202.23M$246M+0.51%
Q1 20201.86M$186M+0.45%
Q4 20191.87M$279M+0.43%
Q3 20191.72M$221M+0.36%
Q2 20191.13M$161M+0.26%
Q1 20191.00M$143M+0.23%
Q4 2018764.5K$95M+0.17%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lsv Asset Management’s full portfolio or all institutional holders of JAZZ.